Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]

Korol AR, Zborovska O, Kustryn T, et al. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol. 2017;11:1315–1320.The Acknowledgement implies that Bayer Pharmaceuticals sponsored the study, this is not correct. The acknowl...

Full description

Bibliographic Details
Main Authors: Korol AR, Zborovska O, Kustryn T, Dorokhova O, Pasyechnikova N
Format: Article
Language:English
Published: Dove Medical Press 2017-08-01
Series:Clinical Ophthalmology
Online Access:https://www.dovepress.com/corrigendum-intravitreal-aflibercept-for-choroidal-neovasculariza-peer-reviewed-article-OPTH
id doaj-e688b2d24370457380265d79bd4cf4cb
record_format Article
spelling doaj-e688b2d24370457380265d79bd4cf4cb2020-11-24T22:59:40ZengDove Medical PressClinical Ophthalmology1177-54832017-08-01Volume 111567156834443Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]Korol ARZborovska OKustryn TDorokhova OPasyechnikova NKorol AR, Zborovska O, Kustryn T, et al. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol. 2017;11:1315–1320.The Acknowledgement implies that Bayer Pharmaceuticals sponsored the study, this is not correct. The acknowledgment should state: The authors take full responsibility for the scope, direction, and content of the manuscript, and have approved the submitted manuscript. Medical writing support was provided by Corey Eagan, MPH, of PAREXEL, and was funded by Bayer Pharmaceuticals. Read the original articlehttps://www.dovepress.com/corrigendum-intravitreal-aflibercept-for-choroidal-neovasculariza-peer-reviewed-article-OPTH
collection DOAJ
language English
format Article
sources DOAJ
author Korol AR
Zborovska O
Kustryn T
Dorokhova O
Pasyechnikova N
spellingShingle Korol AR
Zborovska O
Kustryn T
Dorokhova O
Pasyechnikova N
Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
Clinical Ophthalmology
author_facet Korol AR
Zborovska O
Kustryn T
Dorokhova O
Pasyechnikova N
author_sort Korol AR
title Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
title_short Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
title_full Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
title_fullStr Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
title_full_unstemmed Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
title_sort intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [corrigendum]
publisher Dove Medical Press
series Clinical Ophthalmology
issn 1177-5483
publishDate 2017-08-01
description Korol AR, Zborovska O, Kustryn T, et al. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol. 2017;11:1315–1320.The Acknowledgement implies that Bayer Pharmaceuticals sponsored the study, this is not correct. The acknowledgment should state: The authors take full responsibility for the scope, direction, and content of the manuscript, and have approved the submitted manuscript. Medical writing support was provided by Corey Eagan, MPH, of PAREXEL, and was funded by Bayer Pharmaceuticals. Read the original article
url https://www.dovepress.com/corrigendum-intravitreal-aflibercept-for-choroidal-neovasculariza-peer-reviewed-article-OPTH
work_keys_str_mv AT korolar intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum
AT zborovskao intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum
AT kustrynt intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum
AT dorokhovao intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum
AT pasyechnikovan intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum
_version_ 1725644260730994688